Guilingan, Jesel .
HRN: 27-89-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
10/24/2025
10/31/2025
PO
5mL
TID
Oral Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes